Search Login Register

Prolymphocytic Leukemia Summary

Description: A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA.

Also Known As: Leukemia, Prolymphocytic; Leukemias, Prolymphocytic; Prolymphocytic Leukemias

Networked: 148 relevant articles (14 outcomes, 10 trials/studies) for this Disease

Key Drugs and Agents for Prolymphocytic Leukemia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. fludarabine : 5 outcomes 2 studies in 14 results : IBA
  2. alemtuzumab (Campath) : 3 outcomes 2 studies in 12 results : FDA 2
  3. rituximab (Mabthera) : 2 outcomes 1 study in 6 results : FDA 3
  4. Cyclophosphamide (Cytoxan) : 1 outcome 2 studies in 5 results : FDA 10 Generic
  5. Pentostatin (Nipent) : 1 outcome 1 study in 5 results : FDA 2 Generic
  6. Monoclonal Antibodies : 1 outcome 1 study in 5 results : IBA
  7. Cytarabine (Cytosar-U) : 1 outcome 1 study in 2 results : FDA 13 Generic
  8. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) : 1 outcome 1 study in 1 result : IBA
  9. Cisplatin (Platino) : 1 outcome 1 study in 1 result : FDA 6 Generic
  10. Immunoglobulins (Immunoglobulin) : 1 outcome in 8 results : IBA
Show All >>

Diseases Related to Prolymphocytic Leukemia

  1. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
  2. Leukemia
  3. Non-Hodgkin Lymphoma (Lymphosarcoma)
  4. Hairy Cell Leukemia
  5. Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
Show All >>

Key Therapies for Prolymphocytic Leukemia

Efficacy Chart >>
  1. Radiotherapy : 2 outcomes in 3 results
  2. Stem Cell Transplantation : 1 outcome 1 study in 6 results
  3. Immunotherapy : 1 outcome in 1 result
  4. Transplantation (Transplant Recipients) : 1 study in 3 results
  5. Salvage Therapy : 1 study in 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.